Norges Bank’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,700
Closed -$227K 2045
2023
Q2
$227K Hold
11,700
﹤0.01% 1991
2023
Q1
$332K Sell
11,700
-300
-3% -$8.51K ﹤0.01% 2065
2022
Q4
$351K Hold
12,000
﹤0.01% 2105
2022
Q3
$317K Buy
+12,000
New +$317K ﹤0.01% 2065
2021
Q2
Sell
-85,141
Closed -$3.55M 2269
2021
Q1
$3.55M Sell
85,141
-87,033
-51% -$3.63M ﹤0.01% 1950
2020
Q4
$8.02M Sell
172,174
-11,246
-6% -$524K ﹤0.01% 1810
2020
Q3
$7.79M Sell
183,420
-35,517
-16% -$1.51M ﹤0.01% 1789
2020
Q2
$10.5M Sell
218,937
-4,800
-2% -$230K ﹤0.01% 1702
2020
Q1
$10.3M Sell
223,737
-24,442
-10% -$1.12M ﹤0.01% 1603
2019
Q4
$14.9M Hold
248,179
﹤0.01% 1677
2019
Q3
$14M Hold
248,179
﹤0.01% 1654
2019
Q2
$13.8M Hold
248,179
﹤0.01% 1683
2019
Q1
$12.5M Sell
248,179
-23,568
-9% -$1.19M ﹤0.01% 1723
2018
Q4
$10.9M Buy
271,747
+96,546
+55% +$3.89M ﹤0.01% 1702
2018
Q3
$12.1M Buy
175,201
+25,393
+17% +$1.76M ﹤0.01% 1760
2018
Q2
$11.3M Buy
149,808
+58,691
+64% +$4.44M ﹤0.01% 1772
2018
Q1
$4.8M Hold
91,117
﹤0.01% 1905
2017
Q4
$4.87M Buy
91,117
+18,404
+25% +$983K ﹤0.01% 1874
2017
Q3
$4.34M Sell
72,713
-64,364
-47% -$3.84M ﹤0.01% 1885
2017
Q2
$10.8M Buy
137,077
+21,463
+19% +$1.69M ﹤0.01% 1708
2017
Q1
$9.59M Buy
115,614
+44,606
+63% +$3.7M ﹤0.01% 1749
2016
Q4
$5.63M Hold
71,008
﹤0.01% 1839
2016
Q3
$4.75M Buy
+71,008
New +$4.75M ﹤0.01% 1879